mutLBSgeneDB |
Gene summary for MYLIP |
![]() |
Basic gene Info. | Gene symbol | MYLIP |
Gene name | myosin regulatory light chain interacting protein | |
Synonyms | IDOL|MIR | |
Cytomap | UCSC genome browser: 6p23-p22.3 | |
Type of gene | protein-coding | |
RefGenes | NM_013262.3, | |
Description | E3 ubiquitin ligase-inducible degrader of the low density lipoprotein receptorE3 ubiquitin-protein ligase MYLIPband 4.1 superfamily member BZF1cellular modulator of immune recognition (c-MIR)inducible degrader of the LDL-receptormyosin regulatory lig | |
Modification date | 20141207 | |
dbXrefs | MIM : 610082 | |
HGNC : HGNC | ||
Ensembl : ENSG00000007944 | ||
HPRD : 17621 | ||
Vega : OTTHUMG00000016405 | ||
Protein | UniProt: Q8WY64 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_MYLIP | |
BioGPS: 29116 | ||
Pathway | NCI Pathway Interaction Database: MYLIP | |
KEGG: MYLIP | ||
REACTOME: MYLIP | ||
Pathway Commons: MYLIP | ||
Context | iHOP: MYLIP | |
ligand binding site mutation search in PubMed: MYLIP | ||
UCL Cancer Institute: MYLIP | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0016567 | protein ubiquitination | 14550572 |
Top |
Ligand binding site mutations for MYLIP |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | C387 | M388T | LUSC | 1 | C390 | C391F | OV | 1 | C402 | P401S | SKCM | 1 | C411 | A413T | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for MYLIP |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C387 | M388T | -1.2464559 | C402 | P401S | -1.2057399 | C390 | C391F | -0.17528736 | C411 | A413T | -0.063314943 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for MYLIP |
![]() |
![]() |
Top |
Top |
Phenotype information for MYLIP |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C0014175 | Endometriosis | 1 | Biomarker |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for MYLIP |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ZN | ZINC(2+) | 2yhn | A | C387 C390 C411 | ZN | ZINC(2+) | 2yhn | B | C387 C390 C411 | ZN | ZINC(2+) | 2yho | A | C387 C390 C411 | ZN | ZINC(2+) | 2yho | C | C387 C390 C411 | ZN | ZINC(2+) | 2yho | E | C387 C390 C411 | ZN | ZINC(2+) | 2yho | G | C387 C390 C411 | ZN | ZINC(2+) | 2yhn | A | C402 | ZN | ZINC(2+) | 2yhn | B | C402 | ZN | ZINC(2+) | 2yho | A | C402 | ZN | ZINC(2+) | 2yho | C | C402 | ZN | ZINC(2+) | 2yho | E | C402 | ZN | ZINC(2+) | 2yho | G | C402 |
Top |
Conservation information for LBS of MYLIP |
![]() |
LBS | AA sequence | # species | Species | C387 | KEAMLCMVCCE | 2 | Homo sapiens, Rattus norvegicus | C387 | REALLCMLCCE | 1 | Danio rerio | C387 | KEAMLCMACCE | 1 | Mus musculus | C390 | MLCMVCCEEEI | 2 | Homo sapiens, Rattus norvegicus | C390 | LLCMLCCEEEI | 1 | Danio rerio | C390 | MLCMACCEEEI | 1 | Mus musculus | C402 | STFCPCGHTVC | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C402 | AAFCPCGHMVC | 1 | Danio rerio | C408 | GHTVCCESCAA | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C408 | GHMVCCQNCAA | 1 | Danio rerio | C411 | VCCESCAAQLQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C411 | VCCQNCAAQLQ | 1 | Danio rerio | C418 | AQLQSCPVCRS | 4 | Homo sapiens, Danio rerio, Mus musculus, Rattus norvegicus | C421 | QSCPVCRSRVE | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | C421 | QSCPVCRSEVE | 1 | Danio rerio | H404 | FCPCGHTVCCE | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | H404 | FCPCGHMVCCQ | 1 | Danio rerio |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |